Q: I heard the FDA removed the black box warning from menopause hormone therapy. What does this mean for women?
A: The Federal Drug Administration’s black box warning was originally based on the 2002 Women’s Health Initiative study, which looked at older women, many of whom were well past menopause and had few symptoms. The study focused on heart disease prevention, not relief of menopause symptoms, and early reports overstated the risks. This led many women and physicians to avoid hormone therapy altogether, even when it could have improved quality of life.
Today, we know the risks are much lower for healthy women under 60 or within 10 years of menopause. Hormone therapy is FDA-approved for hot flashes, night sweats, genitourinary symptoms and osteoporosis prevention. Newer formulations, such as bio-identical hormones and transdermal estradiol, are generally safer than older oral options. Timing is important: starting estrogen near menopause can support cardiovascular health, while starting later may carry more risk.
Removing this warning allows women to make informed, individualized decisions with their physicians. Hormone therapy is not a cure-all, but it can be life-changing for those suffering from severe symptoms. Each woman’s personal health history, symptoms and goals should guide whether hormone therapy is appropriate.
Even when using hormone therapy, lifestyle choices remain essential. Regular movement, healthy nutrition, stress management and restorative sleep all support long-term health and overall well-being. With this change, women can now explore the full range of options to improve their quality of life during menopause while still taking a holistic approach to their health.